Vaxart Inc (VXRT)

Dec 21, 2024

Vaxart (NASDAQ:VXRT) Share Price Passes Below 200-Day Moving AverageWhat's Next? - MarketBeat

Dec 21, 2024

Dec 18, 2024

Vaxart Investors Win Class Cert. Over COVID Shot On 2nd Try - Law360

Dec 18, 2024

Dec 18, 2024

Vaxart Investors Get Class Status on Second Try Against Insider - Bloomberg Law

Dec 18, 2024

Dec 18, 2024

Contrasting Tenaya Therapeutics (NASDAQ:TNYA) and Vaxart (NASDAQ:VXRT) - Defense World

Dec 18, 2024

Dec 13, 2024

No time to wait on development of second-generation vaccines - The Hill

Dec 13, 2024

Dec 13, 2024

Vaxart (NASDAQ:VXRT) Share Price Crosses Below 200 Day Moving AverageTime to Sell? - MarketBeat

Dec 13, 2024

Dec 09, 2024

Akin Gump 'Totally Messed Up' With Texts, Vaxart Judge Says - Law360

Dec 09, 2024

Dec 02, 2024

Vaxart Hits Key Milestone in Phase 2b Oral COVID Vaccine Trial, Backed by $456M BARDA Deal - StockTitan

Dec 02, 2024

Nov 29, 2024

Vaxart, Inc. (NASDAQ:VXRT) Shares Sold by Sio Capital Management LLC - MarketBeat

Nov 29, 2024

Nov 27, 2024

Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside - AOL

Nov 27, 2024

Nov 23, 2024

VXRT (Vaxart) Enterprise Value : $95.98 Mil (As of Nov. 23, 2024) - GuruFocus.com

Nov 23, 2024

Nov 21, 2024

B. Riley Has Optimistic Outlook of Vaxart FY2024 Earnings - MarketBeat

Nov 21, 2024

Nov 20, 2024

COVID-19 vaccine company Vaxart under US federal investigation - Telegrafi

Nov 20, 2024

Nov 20, 2024

What is B. Riley's Estimate for Vaxart FY2027 Earnings? - MarketBeat

Nov 20, 2024

Nov 19, 2024

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 19, 2024

Nov 19, 2024

Vaxart Grants 91.5K Equity Awards to New Employees Under Inducement Plan | VXRT Stock News - StockTitan

Nov 19, 2024

Nov 16, 2024

Investors Give Vaxart, Inc. (NASDAQ:VXRT) Shares A 29% Hiding - Simply Wall St

Nov 16, 2024

Nov 16, 2024

Vaxart Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 16, 2024

Nov 16, 2024

Vaxart, Inc. Reports Third Quarter 2024 Financial Results – - Defense World

Nov 16, 2024

Nov 15, 2024

Vaxart, Inc. (NASDAQ:VXRT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Nov 14, 2024

Vaxart, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Nov 14, 2024

Earnings call: Vaxart reports progress in vaccine programs and financial growth - Investing.com

Nov 14, 2024

Nov 14, 2024

Vaxart Inc (NASDAQ: VXRT): Blank Check On Growth? - Stocks Register

Nov 14, 2024

Nov 14, 2024

VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 14, 2024

Nov 14, 2024

Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 14, 2024

Nov 14, 2024

Vaxart Inc (VXRT) Q3 2024 Earnings Call Highlights: Advancements in Oral Vaccine Platform and Financial Growth - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Vaxart Inc (VXRT) Q3 2024 Earnings Call Highlights: Advancements in Oral Vaccine Platform and ... - Yahoo Finance

Nov 14, 2024

Nov 14, 2024

Vaxart Inc reports results for the quarter ended September 30Earnings Summary - XM

Nov 14, 2024

Nov 13, 2024

Vaxart’s Q3 2024: Progress in Oral Vaccine Development - TipRanks

Nov 13, 2024

Nov 13, 2024

Vaxart's Q3 Revenue Jumps 133% to $4.9M, Narrows Losses Amid COVID Trial Progress | VXRT Stock News - StockTitan

Nov 13, 2024

Nov 08, 2024

Vaxart (VXRT) Scheduled to Post Earnings on Wednesday - MarketBeat

Nov 08, 2024

Nov 07, 2024

Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13 - The Manila Times

Nov 07, 2024

Nov 07, 2024

Vaxart (VXRT) Sets Q3 2024 Earnings Call for November 13: Key Updates Coming | VXRT Stock News - StockTitan

Nov 07, 2024

Nov 05, 2024

While shareholders of Vaxart (NASDAQ:VXRT) are in the black over 5 years, those who bought a week ago aren't so fortunate - Simply Wall St

Nov 05, 2024

Nov 01, 2024

Vaxart (NASDAQ:VXRT) Stock Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Nov 01, 2024

Oct 31, 2024

Investing in Vaxart (NASDAQ:VXRT) five years ago would have delivered you a 127% gain - Yahoo Finance

Oct 31, 2024

Oct 24, 2024

VXRTVaxart, Inc Latest Stock News & Market Updates - StockTitan

Oct 24, 2024

Oct 24, 2024

Vaxart (NASDAQ:VXRT) Shares Cross Below 200 Day Moving AverageShould You Sell? - MarketBeat

Oct 24, 2024

Oct 24, 2024

Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024 - StockTitan

Oct 24, 2024

Oct 16, 2024

Millennium Management LLC Has $2.66 Million Stock Holdings in Vaxart, Inc. (NASDAQ:VXRT) - MarketBeat

Oct 16, 2024

Oct 15, 2024

Check out these key findings about Vaxart Inc (VXRT) - SETE News

Oct 15, 2024

Oct 15, 2024

Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need - StockTitan

Oct 15, 2024

Oct 14, 2024

VXRT stock rated an Outperform by Oppenheimer - Knox Daily

Oct 14, 2024

Oct 14, 2024

Did Vaxart Inc (VXRT) perform well in the last session? - US Post News

Oct 14, 2024

Oct 11, 2024

Best Penny Stocks Under $1 To Buy Now - AOL

Oct 11, 2024

Oct 09, 2024

Vaxart Inc (VXRT) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Advances - Yahoo Finance

Oct 09, 2024

Oct 09, 2024

Vaxart ends agreement with sales agents, halts stock sales By Investing.com - Investing.com Australia

Oct 09, 2024

Oct 09, 2024

Vaxart, Inc. Terminates Controlled Equity Offering Sales Agreement with Sales Agents - MarketBeat

Oct 09, 2024

Oct 08, 2024

Vaxart ends agreement with sales agents, halts stock sales - Investing.com India

Oct 08, 2024

Oct 08, 2024

Vaxart Ends Sales Agreement, Halts Stock Offering - TipRanks

Oct 08, 2024